Clinical characteristics and medicine treatment progress in female patients with epilepsy

doi:10.12092/j.issn.1009-2501.2026.02.003

Abstract

Abstract:

Compared with male epilepsy patients, female epilepsy patients have certain clinical characteristics due to factors such as hormone level changes, menstrual cycles, and fertility needs, and the selection of treatment drugs needs to take into account both efficacy and safety, which has certain challenges. This article focuses on the clinical characteristics of female epilepsy patients, especially on the analysis of the different clinical characteristics at different physiological periods. This paper also reviews and prospects the medical treatment options at different periods and new advances in treatment for female patients with epilepsy.

Key words: female epilepsy, pregnancy, anti-seizure medications, hormones

CLC Number:

R742.1

Zhengqing ZHAO, Yanpeng LI, Zhongxin ZHAO. Clinical characteristics and medicine treatment progress in female patients with epilepsy[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(2): 162-167.

References 44

1	Velez-Ruiz NJ, Pennell PB. Issues for women with epilepsy[J]. Neurol Clin, 2016, 34 (2): 411- 425. doi: 10.1016/j.ncl.2015.11.009
2	TaubOll E, Sveberg L, Svalheim S. Interactions between hormones and epilepsy[J]. Seizure, 2015, 28, 3- 11. doi: 10.1016/j.seizure.2015.02.012
3	Razaz N, Tomson T, Wilkstrom AK, et al. Association between pregnancy and perinatal outcomes among women with epilepsy[J]. JAMA Neurol, 2017, 74 (8): 983- 991.
4	Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies[J]. Neurology, 2017, 88 (3): 296- 303. doi: 10.1212/WNL.0000000000003509
5	Kolomar H, Osman A, Blanco LVA, et al. A comprehensive review on the influence of menstrual cycle and pregnancy on epileptic seizures[J]. Cureus, 2025, 17 (3): e80387. doi: 10.7759/cureus.80387
6	Scharfman HE, MacLusky NJ. The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female[J]. Epilepsia, 2006, 47 (9): 1423- 1440. doi: 10.1111/j.1528-1167.2006.00672.x
7	Taubøll E , Isojärvi JIT, Herzog AG. The interactions between reproductive hormones and epilepsy [J]. Handb Clin Neurol, 2021, 182: 155-174.
8	Voinescu PE, Park S, Chen LQ, et al. Antiepileptic drug clearances during pregnancy and clinical implications for women with epilepsy [J]. Neurology, 2018, 91(13): e1228-e1236.
9	Mirawati DK, Wiyono N, Ilyas MF, et al. Research productivity in catamenial epilepsy: a bibliometric analysis of worldwide scientific literature (1956-2022)[J]. Heliyon, 2024, 10 (10): e31474. doi: 10.1016/j.heliyon.2024.e31474
10	Carosella CM, Johnson EL. Special issues in medical management: hormones and pregnancy in epilepsy[J]. Semin Neurol, 2025, 45 (2): 198- 205. doi: 10.1055/a-2551-0688
11	Hessler A, Dolbec K. Seizures: updates in women's health care primary and preventive care review[J]. Obstet Gynecol, 2021, 137 (1): 207.
12	Li YX, Guo W, Chen RX, et al. The relationships between obesity and epilepsy: a systematic review with meta-analysis[J]. PLoS One, 2024, 19 (8): e0306175. doi: 10.1371/journal.pone.0306175
13	Josephson CB, Gonzalez-Izquierdo A, Denaxas S, et al. Independent associations of incident epilepsy and enzyme-inducing and non-enzyme-inducing antiseizure medications with the development of osteoporosis[J]. JAMA Neurol, 2023, 80 (8): 843- 850. doi: 10.1001/jamaneurol.2023.1580
14	Qin SK, Yang ZX, Guan ZW, et al. Exploring the association between epilepsy and depression: a systematic review and meta-analysis[J]. PLoS One, 2022, 17 (12): e0278907. doi: 10.1371/journal.pone.0278907
15	Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the international league against epilepsy: Position paper of the ILAE commission for classification and terminology[J]. Epilepsia, 2017, 58 (4): 522- 530. doi: 10.1111/epi.13670
16	Maguire MJ, Nevitt SJ. Treatments for seizures in catamenial (menstrual-related) epilepsy[J]. Cochrane Database Syst Rev, 2021, 9 (9): CD013225. doi: 10.1002/14651858.cd013225.pub2
17	Nucera B, Rinaldi F, Dono F, et al. Progesterone and its derivatives for the treatment of catamenial epilepsy: a systematic review[J]. Seizure, 2023, 109 (7): 52- 59. doi: 10.1016/j.seizure.2023.05.004
18	Joshi S, Sun H, Rajasekaran K, et al. A novel therapeutic approach for treatment of catamenial epilepsy[J]. Neurobiol Dis, 2018, 111, 127- 137. doi: 10.1016/j.nbd.2017.12.009
19	Shiono S, Williamson J, Kapur J, et al. Progesterone receptor activation regulates seizure susceptibility[J]. Ann Clin Transl Neurol, 2019, 6 (7): 1302- 1310. doi: 10.1002/acn3.50830
20	中华医学会神经病学分会脑电图与癫痫学组. 中国围妊娠期女性癫痫患者管理指南[J]. 中华神经科杂志, 2021, 54 (6): 539- 544. doi: 10.3760/cma.j.cn113694-20201116-00879
21	Tomson T, Battino D, Bonizzoni E, et al. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry [J]. Lancet Neurol, 2018, 17(6): 530-538.
22	Hernandez-Diaz S, Smith CR, Shen A, et al. Comparative safety of antiepileptic drugs during pregnancy [J]. Neurology, 2012, 78(21): 1692-1699.
23	Tomson T, Battino D, Bonizzoni E, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry [J]. Lancet Neurol, 2011, 10(7): 609-617.
24	Weston J, Bromley R, Jackson CF, et al. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child[J]. Cochrane Database Syst Rev, 2016, 11 (11): CD010224. doi: 10.1002/14651858.cd010224.pub2
25	Karanam A, Pennell PB, Meador KJ, et al. Characterization of lamotrigine disposition changes during and after pregnancy in women with epilepsy[J]. Pharmacotherapy, 2025, 45 (1): 33- 42. doi: 10.1002/phar.4640
26	Molgaard-Nielsen D, Hviid A. Newer-generation antiepileptic drugs and the risk of major birth defects [J]. JAMA, 2011, 305(19): 1996-2002.
27	Tomson T, Battino D, Bonizzoni E, et al. Declining malformation rates with changed antiepileptic drug prescribing: an observational study [J]. Neurology, 2019, 93(9): e831-e840.
28	Cohen MJ, Meador KJ, May R, et al. Fetal antiepileptic drug exposure and learning and memory functioning at 6 years of age: The NEAD prospective observational study [J]. Epilepsy Behav, 2019, 92: 154-164.
29	Adab N, Kini U, Vinten J, et al. The longer term outcome of children born to mothers with epilepsy [J]. J Neurol Neurosurg Psychiatry, 2004, 75(11): 1575-1583.
30	Reisinger TL, Newman M, Loring DW, et al. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy [J]. Epilepsy Behav, 2013, 29(1): 13-18.
31	Tomson T, Landmark CJ, Battino D. Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications [J]. Epilepsia, 2013, 54(3): 405-414.
32	Birnbaum AK, Meador KJ, Karanam A, et al. Antiepileptic drug exposure in infants of breastfeeding mothers with epilepsy [J]. JAMA Neurol, 2020, 77(4): 441-450.
33	Meador KJ, Baker GA, Browning N, et al. Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years[J]. JAMA Pediatr, 2014, 168 (8): 729- 736.
34	Sourbron J, Auvin S, Cabral-Lim L, et al. Vitamin D prophylaxis in persons with epilepsy?[J]. Epilepsia, 2024, 65 (9): 2567- 2579. doi: 10.1111/epi.18046
35	Uçan Tokuç FE, Fatma G, Abidin E, et al. Management of bone metabolism in epilepsy[J]. Ideggyogy Sz, 2021, 74 (7/8): 257- 265. doi: 10.18071/isz.74.0257
36	Lambrinoudaki I, Kaparos G, Armeni E, et al. BsmI vitamin D receptor's polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy[J]. Eur J Neurol, 2011, 18 (1): 93- 98. doi: 10.1111/j.1468-1331.2010.03103.x
37	Carvalho V, Colonna I, Curia G, et al. Sex steroid hormones and epilepsy: effects of hormonal replacement therapy on seizure frequency of postmenopausal women with epilepsy-A systematic review[J]. Eur J Neurol, 2023, 30 (9): 2884- 2898. doi: 10.1111/ene.15916
38	Yamamoto Y, Akita N, Nogimoto H, et al. Changes in perampanel pharmacokinetics and cytochrome P450 3A4 activity before, during, and after pregnancy[J]. Ther Drug Monit, 2024, 46 (4): 548- 551. doi: 10.1097/FTD.0000000000001195
39	Hoeltzenbein M, Slimi S, Fietz AK, et al. Increasing use of newer antiseizure medication during pregnancy: an observational study with special focus on lacosamide[J]. Seizure, 2023, 107, 107- 113. doi: 10.1016/j.seizure.2023.02.015
40	Vazquez B, Tomson T, Dobrinsky C, et al. Perampanel and pregnancy[J]. Epilepsia, 2021, 62 (3): 698- 708. doi: 10.1111/epi.16821
41	Barry JM, Illamola SM, Pennell PB, et al. Prediction of lacosamide concentrations to support dose optimization during pregnancy[J]. Epilepsia, 2025, 66 (2): 346- 355. doi: 10.1111/epi.18184
42	Pennell PB, Karanam A, Meador KJ, et al. Antiseizure medication concentrations during pregnancy: results from the maternal outcomes and neurodevelopmental effects of antiepileptic drugs (MONEAD) study[J]. JAMA Neurol, 2022, 79 (4): 370- 379. doi: 10.1001/jamaneurol.2021.5487
43	Navarro CE. A healthy outcome of a pregnant woman with drug-resistant juvenile myoclonic epilepsy treated with brivaracetam[J]. Neurol Sci, 2023, 44 (2): 753- 755. doi: 10.1007/s10072-022-06444-7
44	Clayton LM, Vakrinou A, Balestrini S, et al. Monogenic epilepsies in adult epilepsy clinics and gene-driven approaches to treatment[J]. Curr Neurol Neurosci Rep, 2025, 25 (1): 35. doi: 10.1007/s11910-025-01413-x

[1]	ZHU Chengcheng, LUO Yonghong, DING Jin, CHENG Huixian, NI Guantai. Application of pneumoperitoneum-free single-hole endoscopy combined with ropivacaine in pregnancy with ovarian tumor [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 561-568.
[2]	LI Zhimin, LI Shiran, XIE Jingxian, ZHANG Jiao, LI Pengfei, ZENG Siyu, YANG Yong. Advances in diagnosis, treatment and management of hypertriglyceridemia in pregnancy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(12): 1380-1388.
[3]	ZHOU Xiaoshi, LI Shiran, ZENG Siyu, LI Guolin, ZHANG Changji, YANG Yong. Advancements in the application of biologics for rheumatic autoimmune diseases in pregnancy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(12): 1389-1400.
[4]	LIU Xin, LENG Yufang, ZHANG Xuehong, ZHANG Lili, ZHANG Mengjie, QU Shanshan, XIE Jianqin, WANG Yiqing. Application of nalbuphine in ultrasound-guided transvaginal oocyte retrieval and its effect on embryo quality and pregnancy outcome [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 1042-1047.
[5]	JIANG Weijie, HE Haibo, TANG Hongbo, HE Junyu. Research progress on the relationship between nuclear factor-κB in placenta and pregnancy complications [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(1): 82-87.
[6]	WANG Sijie，ZHANG Jun，LI Qian，HUANG Hua，WANG Jingjing，ZHOU Qiong，YAO Qin. Research progress on the safety and effectiveness of escitalopram in the treatment of pregnant women with depression [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 1070-1074.
[7]	YING Jiawei，WU Liang，SHENG Shaoqin. Clinical study on the treatment of salvia ligustrazine injection on pregnant women with ICP in late pregnancy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(4): 446-450.
[8]	ZHOU Yancan, PING Jing, SHAN Jianmin. Effects of Wuling capsule combined with agomelatin in female patients with depression and sleep disorders and its effect on neurotransmitters and endocrine hormones [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(12): 1415-1419.
[9]	YAN Lin, WANG Jingjing, HUANG Hua, YAO Qin, LI Qian, ZHANG Jun. Application of immunosuppressive agents in pregnancy after organ transplantation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(11): 1317-1320.
[10]	JIN Congcong, WANG Peiyu, LIN Jia, ZHOU Wei, YANG Haiyan. A comparison of clinical applications of transdermal estradiol and estradiol valerate on endometrial receptivity in frozen-thawed embryo transfer cycles [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(10): 1162-1166.
[11]	DU Xiang-hui, JI Yong-lin, WANG Xiao-jia. The influence of the drug on the fetus of diagnosis and treatment of breast cancer during pregnancy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(2): 206-213.
[12]	XIONG Qin-mei, HONG Kui. Survey on anticoagulant therapy in pregnant women with cardiovascular disease [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(2): 223-227.
[13]	ZHANG Nan, HE Lian-zhi. Analysis of long-dated security and effectiveness for high-grade cervical intraepithelial neoplasia with loop electrosurgical excision procedure [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(12): 1411-1415.
[14]	YAN Xiao-lin, PENG Jun, DING Qi-long. Nongenomic actions of thyroid hormone and the cardiovascular function [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(5): 586-591.
[15]	CHEN Jun-xia, WANG Yun-gen, SHAN Jiang-jing, RUAN Ya-wen. Efficacy comparison of two methotrexate regimen in the non-surgical treatment for ectopic pregnancy with different pre-treatment β-HCG rising ratio [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(11): 1270-1274.